Introduction
Patients on regular haemodialysis at Newcastle upon Tyne have a high incidence of osteomalacia, which is characterised by bone pain, pathological fractures, myopathy, and reduced physical activity.' 2 Comparison with another British centre confirmed this but showed no obvious differences in dialysis technique.3 Drug treatment, other than with heparin, vitamin D, calcium supplements, and phosphate binders was not taken into consideration. During the 1960s barbiturates were given regularly at night to patients on dialysis and some of the long-term survivors continued to take them until recently. Prolonged anticonvulsant treatment was given to patients who had convulsions early in the course of their management. Because of the association between anticonvulsants and osteomalacia in epilepsy4 5 we decided to review the drug treatment of all the patients who had at any time completed not less than four years on regular haemodialysis at Newcastle and to relate it to the incidence of osteomalacia in these patients.
Renal osteodystrophy resolves rapidly after successful renal transplantation. 6 7 The different histological components resolve at different rates, but osteomalacia usually heals promptly. In 81°' of our patients with histological evidence of osteomalacia at the time of transplantation the changes had completely resolved a year later.7 Surprisingly, however, in a few patients with adequate renal function osteomalacia progressed or developed afresh after successful transplantation. Review of these patients showed that many had been treated with anticonvulsants or sedatives for long periods after transplantation.
Patients and methods
Bone histopathology had been studied in serial transiliac bone biopsies. Osteomalacia was diagnosed only when there was an excess of osteoid, with abnormally thick osteoid seams comprising five or more birefringent lamellae, and a reduced or absent calcification front.8 Radiological skeletal surveys had been carried out at six-monthly intervals. Serum calcium had been measured by atomic absorption spectrophotometry,9 and all values corrected to a total serum protein level of 72 g/l. Serum alkaline phosphatase had been measured by a modification of the method of Bowers and McComb.'°T hirty-nine patients had completed four or more years of regular haemodialysis. Some of them had subsequently been transplanted or died. Complete records of drug treatment were available from their dialysis sheets. Questionnaires on symptoms and records of physical examination had been completed at six-monthly follow-up visits, from which we assessed the degree of bone pain, muscle weakness, and physical activity.
Fifty-eight transplant recipients followed up in the transplant clinic had had a full reassessment of bone status at one year. Their drug treatment was also reviewed. Seven (12%) had had histological evidence of osteomalacia, and of these 5 (71 %) had received prolonged treatment with enzyme-inducing drugs. The case histories of these five patients are given below. CASE 
1
A 30-year-old woman received a cadaveric renal transplant on 20 March 1972, three years after beginning regular haemodialysis. After about nine months of regular haemodialysis she had developed symptomatic bone disease, which progressed to pronounced weakness of her quadriceps and difficulty with walking. Osteomalacia was confirmed by transiliac bone biopsy after 14, 27, and 36 months of regular haemodialysis, but no evidence of osteitis fibrosa was found. There was a progressive loss of total and mineralised bone and an increasing thickness of patchily distributed osteoid seams. The bone biopsy specimen taken at 36 months, on the day of transplantation, showed: total bone (TB) 14 
Results
Of the 39 patients who completed four years on regular haemodialysis 23 had received barbiturates for six months or more as either anticonvulsants or hypnotics and 16 had taken no nocturnal sedatives or had received nitrazepam alone; in non-uraemic people nitrazepam does not induce hepatic microsomal enzymes.'" Signs of hyperparathyroidism such as subperiosteal~rosions in the hands did not differ significantly in the two groups. Those taking barbiturates had more bone pain and myopathy and were less physically active, but the differences were not significant at the level. They had, however, significantly more pathological fractures and a greater incidence of histological osteomalacia (table II) .
In four of the five patients described above osteomalacia had been present at the time of transplantation, but they differed from most patients with this lesion in that it failed to heal spontaneously by the end of the first year. In case 2 osteomalacia appeared as a new finding Introduction Prednisolone-21-phosphate administered as a retention enema is valuable in treating colitis' but there is doubt about how much prednisolone is absorbed from such enemas. Since it has hitherto been impossible to measure small quantities of prednisolone in blood samples observations on the absorption of prednisolone from the rectum have been indirect. Recent advances in the measurement of prednisolone by competitive protein binding2 and by radioimmunoassay3 have allowed nanogram quantities of the steroid to be measured directly in plasma. We describe here the use of a competitive protein-binding method to measure the amount of prednisolone absorbed from the rectum. We compared the levels observed after an oral dose of prednisolone with those after an equivalent dose given by retention enema in the same patient.
Patients and methods
Prednisolone was measured in 2-ml plasma samples using a competitive protein-binding assay2 modified as described by Wilson 
